Machine Learning-Assisted Metabolomics Analysis
Also known as: ML-metabolomics, chemoinformatics ML, metabolite profiling with machine learning, ML-driven metabolic profiling
Machine learning-assisted metabolomics analysis is an integrative bioinformatics pipeline that couples untargeted or targeted metabolite profiling — via mass spectrometry or NMR — with supervised and unsupervised ML algorithms to discover biomarkers, classify phenotypes, and model metabolic states. By handling the extreme dimensionality and collinearity inherent in metabolomics datasets (hundreds to thousands of features, tens to hundreds of samples), ML methods such as random forests, support vector machines, and neural networks extract biologically interpretable patterns that classical univariate statistics routinely miss.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Use this pipeline when you have a high-dimensional metabolomics dataset (typically >100 features) and a defined biological question — biomarker discovery, phenotype classification, response prediction, or pathway activity estimation. It is appropriate for both untargeted global profiling studies and targeted panels. It is NOT appropriate when sample sizes are very small (fewer than ~30 samples per class) without strict cross-validation controls, because overfitting risk is severe. Do not apply supervised ML without a clearly pre-specified outcome variable and a validation strategy; exploratory fishing with ML and post-hoc p-value reporting is a well-documented source of irreproducible findings in metabolomics.
Strengths & limitations
- Handles the inherent high dimensionality and multicollinearity of metabolomics data that invalidates classical univariate approaches.
- Captures non-linear, interaction-driven metabolic patterns that linear models miss.
- Produces ranked variable importance scores that directly guide biological interpretation and pathway analysis.
- Ensemble methods such as random forests are intrinsically robust to outlier samples and moderate class imbalance.
- Applicable across metabolomics platforms (LC-MS, GC-MS, NMR) and study designs (case-control, longitudinal, multi-omics).
- When properly validated, supports clinically actionable biomarker panels with quantified predictive performance.
- Requires careful preprocessing; errors in normalisation or batch correction propagate and can dominate ML outputs.
- Prone to severe overfitting when sample sizes are small relative to feature count — a chronic problem in metabolomics studies.
- Most high-performance models (gradient boosting, deep learning) are black boxes; mechanistic interpretation requires additional post-hoc tools such as SHAP.
- Feature annotation (linking MS peaks to known metabolites) remains incomplete; a powerful predictive feature may be an unannotated or misannotated compound.
- Computational choices (algorithm, hyperparameters, validation scheme) are numerous and poorly standardised across the field, hampering reproducibility.
Frequently asked
How many samples do I need for a reliable ML-metabolomics study?
There is no universal threshold, but a common practical guideline is at least 30–50 samples per class for supervised classification. With fewer samples, nested cross-validation and permutation testing become mandatory and results should be treated as exploratory. Studies with fewer than 20 samples per class are at high risk of overfitting regardless of the algorithm used, and independent external validation on a separate cohort is strongly advisable before any clinical or translational claim.
Is PLS-DA a machine learning method?
PLS-DA is a supervised multivariate method that sits at the boundary between classical chemometrics and machine learning. It is widely used in metabolomics and shares core properties with ML — it learns a discriminant projection from labelled training data and predicts class membership. However, it is a linear model and less flexible than ensemble or deep learning methods. It remains a reasonable first-choice classifier when samples are limited, provided that cross-validation and permutation testing are applied rigorously.
What is the difference between untargeted and targeted metabolomics in this context?
Untargeted metabolomics measures all detectable metabolites simultaneously (hundreds to thousands of features) without prior selection, making it suitable for discovery. Targeted metabolomics measures a predefined set of metabolites with higher accuracy and reproducibility, making it suitable for validation and clinical assays. ML methods are applied to both, but the feature selection and preprocessing steps differ: untargeted data require extensive annotation and filtering, while targeted data are often ready for direct modelling after standard QC.
Should I use SHAP values for interpretation?
SHAP (SHapley Additive exPlanations) values are recommended for any non-linear or ensemble model (random forest, gradient boosting, neural network) because they provide a theoretically grounded, consistent decomposition of each prediction into per-feature contributions. They are superior to raw feature importance scores from random forests, which are biased toward high-cardinality features. For linear models such as PLS-DA, VIP scores or regression coefficients are conventional and interpretable without SHAP.
Which tools or software are standard for this pipeline?
MetaboAnalyst (web-based, R back-end) is the most widely used platform for preprocessing, statistical analysis, and pathway mapping in metabolomics. For ML steps, Python libraries (scikit-learn, XGBoost, SHAP) and R packages (caret, mlr3, mixOmics) are common. XCMS and MZmine handle LC-MS peak detection and alignment. For multi-omics integration, MOFA+ and mixOmics DIABLO are established frameworks.
Sources
- Liebal, U. W., Phan, A. N. T., Sudhakar, M., Raman, K., & Blank, L. M. (2020). Machine learning applications for mass spectrometry-based metabolomics. Metabolites, 10(6), 243. DOI: 10.3390/metabo10060243 ↗
- Bylesjö, M., Rantalainen, M., Cloarec, O., Nicholson, J. K., Holmes, E., & Trygg, J. (2006). OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. Journal of Chemometrics, 20(8-10), 341-351. link ↗
How to cite this page
ScholarGate. (2026, June 3). Machine Learning-Assisted Metabolomics Analysis. ScholarGate. https://scholargate.app/en/bioinformatics/machine-learning-assisted-metabolomics-analysis
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Random ForestMachine learning↔ compare